Antithymocyte Globulin and Sirolimus in Treating Patients With Relapsed Multiple Myeloma

Clinical trial NCT00317798 · COMPLETED

Trial details

NCT number: NCT00317798
Sponsor: University of Rochester
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Drug/Agent Toxicity by Tissue/Organ Multiple Myeloma and Plasma Cell Neoplasm

Start date: 2006-04-01
Primary completion: 2011-04-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.